Generic Indocin is used for treating moderate to severe rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout or certain types of bursitis and tendonitis. More info »
Generic Indocin Sustained-Release is used for treating moderate to severe rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout or certain types of bursitis and tendonitis. More info »
Your email was addressed as a survey and the only link was the one I am responding to now.
To question #1; Did I receive the medication shipment as ordered?
The answer is yes, and I was impressed with the time in which it was delivered to my home; only 10 days!
To question #2; did the medication meet my expectations?
Again the answer is yes! I was also impressed with your website which explains everything about ordering outside the U.S., quality of the medication made at the India labs, number(s) to call if the shipment is held up in Customs, and the ease in placing the order.
- Dave
Cobiprostone Preclinical Data from NSAID-Induced Gastric Mucosal Injury Models ... - EON: Enhanced Online News (press release)
Cobiprostone Preclinical Data from NSAID-Induced Gastric Mucosal Injury Models .
Sucampo Presents Preclinical Data Showing Protective Effect Of Cobiprostone - NASDAQ
Sucampo Presents Preclinical Data Showing Protective Effect Of CobiprostoneNASDAQIn the study presented, treatment with the NSAID indomethacin resulted in increased permeability due to dysregulation of occludin co-localization.
SUCAMPO PHARMACEUTICALS, INC. : Cobiprostone Preclinical Data from NSAID ... - 4-traders
SUCAMPO PHARMACEUTICALS, INC.
Iroko Pharmaceuticals Engages SynopiaRx to Navigate Managed Care Landscape - MarketWatch (press release)
Iroko Pharmaceuticals Engages SynopiaRx to Navigate Managed Care LandscapeMarketWatch (press release)In addition to Iroko's two marketed products -- Indocin(R) (indomethacin) and Aldomet(R) (methyldopa) -- and commercial infrastructure in 48 countries, the company has a robust pipeline with several late stage NSAID sub-micron technology candidates .
PLx Pharma Files New Drug Application with FDA and Adds New Board Member - MarketWatch (press release)
PLx Pharma Files New Drug Application with FDA and Adds New Board MemberMarketWatch (press release)PLx is a pharmaceutical company developing gastrointestinal (GI) safer formulations of proven non-steroidal anti-inflammatory drugs (NSAIDs) including aspirin, ibuprofen and indomethacin as well as other drugs for Over-the-Counter and prescription .